{"nct_id":"NCT06163326","title":"A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2024-01-19","start_date_type":"ACTUAL","primary_completion_date":"2027-04-23","primary_completion_date_type":"ESTIMATED","completion_date":"2027-04-23","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["PFE"]}